1996
DOI: 10.1016/0378-5173(96)04504-8
|View full text |Cite
|
Sign up to set email alerts
|

Novel peroral dosage forms with protease inhibitory activities. II. Design of fast dissolving poly(acrylate) and controlled drug-releasing capsule formulations with trypsin inhibiting properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…Recently, researchers have described the nucleation of calcium phosphate crystals on the surface of poly(2-hydroxyethyl methacrylate) polymers which were chemically modified by carboxy-methylation [23]. Other studies have shown that carboxyl-containing molecules are good binders of calcium [24][25][26] and when incorporated into a calcium phosphate material, these molecules were slowly released from the carrier [16].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, researchers have described the nucleation of calcium phosphate crystals on the surface of poly(2-hydroxyethyl methacrylate) polymers which were chemically modified by carboxy-methylation [23]. Other studies have shown that carboxyl-containing molecules are good binders of calcium [24][25][26] and when incorporated into a calcium phosphate material, these molecules were slowly released from the carrier [16].…”
Section: Discussionmentioning
confidence: 99%
“…These systems have been developed to protect orally administered peptide-based drugs from enzymatic degradation in the gastrointestinal lumen. Some mucoadhesive polymers including carbomer could also act as weak enzyme inhibitors [ 133 ], however, chitosan lacks this property. Examples of enzyme inhibitors include antipain, chymostatin, elastatinal and Bowman-Birk inhibitor [ 134 ].…”
Section: Mucoadhesive Chitosan Derivativesmentioning
confidence: 99%
“…Moreover, it has also been posited that soy isoflavones inhibit insulin release from the pancreas and glucose uptake into the intestinal brush border by restraining protein tyrosine kinase activity (Akiyama et al, 1996) or decreasing sodium-dependent glucose transporters (Vedavanam et al, 1999). An alternative hypothesis is that soy isoflavones are a marker of a healthy soy-based diet.…”
Section: Resultsmentioning
confidence: 99%